ADVFN ADVFN

Hot Features

Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Tempest Therpeutics Inc

Tempest Therpeutics Inc (TPST)

1.27
0.00
(0.00%)
終了 6月9日 5:00AM
1.2643
-0.0057
( -0.45% )
プレマーケット: 5:56PM

Tempest Therpeutics Inc (TPST) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
1.2643
( -0.45% )
買値
1.26
売値
1.31
出来高
562
0.00 日の範囲 0.00
1.23 52 週間の範囲 12.23
時価総額
前日終値
1.27
始値
-
最終取引時間
17:56:47
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 201,585
発行済株式数
14,344,034
配当利回り
PER
-0.29
1 株当たり利益 (EPS)
-7.15
歳入
-
純利益
-43.1M

Tempest Therpeutics Inc について

Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unr... Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma that completed Phase 2 clinical trial; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Brisbane, United States
設立
-
Tempest Therpeutics Inc is listed in the Healthcare sector of the ナスダック市場 with ticker TPST. The last closing price for Tempest Therpeutics was US$1.27. Over the last year, Tempest Therpeutics shares have traded in a share price range of US$ 1.23 to US$ 12.23.

Tempest Therpeutics currently has 14,344,034 shares in issue. The market capitalisation of Tempest Therpeutics is US$18.14 million. Tempest Therpeutics has a price to earnings ratio (PE ratio) of -0.29.

TPST 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.1657-11.58741258741.431.431.231336801.29055213CS
4-0.6557-34.15104166671.922.121.231274401.64231646CS
12-0.9957-44.05752212392.262.461.232140821.85283571CS
26-1.8857-59.86349206353.153.231.231519162.10905392CS
52-10.0357-88.811504424811.312.231.231349294.35470919CS
156-0.1157-8.384057971011.3812.230.1717467054.12414996CS
260-12.5457-90.845039826213.81410.1711237984.55716049CS

TPST - Frequently Asked Questions (FAQ)

What is the current Tempest Therpeutics Inc share price?
The current share price of Tempest Therpeutics Inc is US$ 1.2643
How many Tempest Therpeutics Inc shares are in issue?
Tempest Therpeutics Inc has 14,344,034 shares in issue
What is the market cap of Tempest Therpeutics Inc?
The market capitalisation of Tempest Therpeutics Inc is USD 18.14M
What is the 1 year trading range for Tempest Therpeutics Inc share price?
Tempest Therpeutics Inc has traded in the range of US$ 1.23 to US$ 12.23 during the past year
What is the PE ratio of Tempest Therpeutics Inc?
The price to earnings ratio of Tempest Therpeutics Inc is -0.29
What is the registered address of Tempest Therpeutics Inc?
The registered address for Tempest Therpeutics Inc is 2000 Sierra Point Parkway, Brisbane, California, 94005
What is the Tempest Therpeutics Inc website address?
The website address for Tempest Therpeutics Inc is www.tempesttx.com
Which industry sector does Tempest Therpeutics Inc operate in?
Tempest Therpeutics Inc operates in the Biotechnology & Life Sciences sector

TPST 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

TPST Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock